Structures by: Capel Berdiell I. Z.
Total: 38
Octakis[2,4-di(pyrazol-1-yl)-1,3,5-triazine]-tetrairon(II) octa-tetrafluoroborate hemi[2-(trifluoroboryl)-1H-pyrazole] acetonitrile (8/5.9) solvate
C72H56Fe4N56,8(BF4),0.5(C3H4BF3N2),5.9(C2H3N1)
Dalton Transactions (2019)
a=16.1862(6)Å b=17.2352(5)Å c=23.7427(7)Å
α=97.839(2)° β=91.234(3)° γ=105.400(3)°
Catena-[2,4-di(4-chloropyrazol-1-yl)-6H-1,3,5-triazine]-(acetonitrile)silver(I) perchlorate
C11H8AgCl3N8O4
Dalton Transactions (2019)
a=13.5601(2)Å b=8.2545(1)Å c=15.4017(3)Å
α=90.00° β=95.121(1)° γ=90.00°
[2,4-Di(3,5-dimethylpyrazol-1-yl)-1,3,5-triazine](acetonitrile)-silver(I) perchlorate
C15H18AgN8,ClO4
Dalton Transactions (2019)
a=7.7857(3)Å b=11.0383(5)Å c=12.5260(5)Å
α=74.006(4)° β=71.927(4)° γ=71.187(4)°
Tetrakis-[2,4-di(3,5-dimethylpyrazol-1-yl)-1,3,5-triazine]-tetrasilver(I) tetraperchlorate hydrate nitromethane solvate
C52H60Ag4N28,4(ClO4),3.2(CH3NO2),1.2(H2O)
Dalton Transactions (2019)
a=20.8911(9)Å b=27.7398(10)Å c=15.8143(7)Å
α=90.00° β=107.315(5)° γ=90.00°
Bis-[4,6-di(pyrazol-1-yl)pyrimidine]-di[isothiocyanato]iron(II)
C22H16FeN14S2
Dalton Transactions (2019)
a=8.1002(4)Å b=11.5650(6)Å c=14.0754(7)Å
α=101.393(4)° β=93.048(4)° γ=91.065(4)°
Tetrakis-[2,4-di(3,5-dimethylpyrazol-1-yl)-6H-1,3,5-triazine)]-tetrasilver(I) tetra-perchlorate
C52H60Ag4N28,4(ClO4)
Dalton Transactions (2019)
a=13.9144(2)Å b=13.9144(2)Å c=17.8688(3)Å
α=90.00° β=90.00° γ=90.00°
Tetrakis-[2,4-di(4,5,6,7-tetrahydroindazol-2-yl)-6H-1,3,5-triazine]-tetrasilver(I) tetraperchlorate nitromethane solvate
C68H76Ag4N28,4(ClO4),CH3NO2
Dalton Transactions (2019)
a=20.7165(11)Å b=33.8226(13)Å c=15.6449(6)Å
α=90.00° β=131.404(3)° γ=90.00°
Tetrakis-[2,4-di(3,5-dimethylpyrazol-1-yl)-6H-1,3,5-triazine)]-tetrasilver(I) tetra-hexafluoroantimonate nitromethane solvate
C52H60Ag4N28,4(F6Sb),CH3NO2
Dalton Transactions (2019)
a=22.9855(3)Å b=14.9629(3)Å c=23.3614(3)Å
α=90.00° β=95.028(1)° γ=90.00°
Bis-[4,6-di(pyrazol-1-yl)pyrimidine]-di[isoselenocyanato]iron(II)methanol solvate
C22H16FeN14Se2,CH4O
Dalton Transactions (2019)
a=12.9026(2)Å b=14.5475(2)Å c=16.1511(2)Å
α=90.00° β=109.427(2)° γ=90.00°
2-Amino-4,6-(pyrazol-1-yl)pyrimidine
C10H9N7
Dalton Transactions (2019)
a=17.0960(11)Å b=10.5273(4)Å c=13.4500(6)Å
α=90.00° β=121.235(4)° γ=90.00°
Catena-[2-amino-4,6-(pyrazol-1-yl)pyrimidine]-di-isoselenocyanato iron(II)
C12H9FeN9Se2
Dalton Transactions (2019)
a=16.4591(3)Å b=16.4591(3)Å c=25.0804(6)Å
α=90.00° β=90.00° γ=90.00°
2,4-Bis(4-chloropyrazol-1-yl)-6H-1,3,5-triazine acetonitrile solvate
C9H5Cl2N7,C2H3N
Dalton Transactions (2019)
a=3.9058(4)Å b=16.7955(15)Å c=20.5409(9)Å
α=90.00° β=90.00° γ=90.00°
Catena-[2-methyl-4,6-(pyrazol-1-yl)pyrimidine]-di-isothiocyanato iron(II)
C13H10FeN8S2
Dalton Transactions (2019)
a=16.1912(6)Å b=16.1912(6)Å c=25.146(3)Å
α=90.00° β=90.00° γ=90.00°
Catena-[4,6-(pyrazol-1-yl)pyrimidine]-diaquairon(II) diperchlorate
C10H11FeN6O2,2(ClO4)
Dalton Transactions (2019)
a=20.888(2)Å b=9.323(2)Å c=19.916(2)Å
α=90.00° β=113.519(13)° γ=90.00°
2,4-Bis(4,5,6,7-tetrahydroindazol-2-yl)-6H-1,3,5-triazinedichloroform solvate
C17H19N7,2(CHCl3)
Dalton Transactions (2019)
a=9.3073(3)Å b=11.3030(3)Å c=23.5856(8)Å
α=88.648(2)° β=86.046(3)° γ=87.961(2)°
Bis-[4,6-di(pyrazol-1-yl)pyrimidine]-di[isoselenocyanato]iron(II)hemi-ethanol solvate
C22H16FeN14Se2,0.5(C2H6O)
Dalton Transactions (2019)
a=12.6992(7)Å b=14.4699(6)Å c=16.2226(9)Å
α=90.00° β=108.645(6)° γ=90.00°
Bis-[4,6-di(pyrazol-1-yl)pyrimidine]-di[isothiocyanato]iron(II)methanol solvate
C22H16FeN14S2,CH4O
Dalton Transactions (2019)
a=13.1916(3)Å b=14.3276(3)Å c=15.8098(4)Å
α=90.00° β=110.841(2)° γ=90.00°
Bis-[2-methyl-4,6-(pyrazol-1-yl)pyrimidine]-di-isoselenocyanato iron(II)
C24H20FeN14Se2
Dalton Transactions (2019)
a=8.1773(4)Å b=12.1684(6)Å c=14.1965(8)Å
α=77.437(4)° β=83.062(4)° γ=89.966(4)°
Bis-[4,6-di(pyrazol-1-yl)pyrimidine]-di[isoselenocyanato]iron(II)hemi-acetone solvate
C22H16FeN14Se2,0.5(C3H6O)
Dalton Transactions (2019)
a=12.7269(5)Å b=14.6440(6)Å c=16.1908(7)Å
α=90.00° β=109.447(4)° γ=90.00°
2-(Pyrazol-1-yl)-6-(1,2,4-triazol-1-yl)pyridine
C10H8N6
CrystEngComm (2019) 21, 42 6330
a=12.5794(9)Å b=3.8549(3)Å c=20.4981(14)Å
α=90.00° β=103.627(7)° γ=90.00°
2-Fluoro-6-(pyrazol-1-yl)pyridine
C8H6FN3
CrystEngComm (2019) 21, 42 6330
a=4.0393(1)Å b=11.2187(4)Å c=16.2922(4)Å
α=90.00° β=90.00° γ=90.00°
Catena-Bis-[/m-{2-(pyrazol-1-yl)-6-(1,2,4-triazol-1-yl)pyridine}]- bis [2-(pyrazol-1-yl)-6-(1,2,4-triazol-1-yl)pyridine]diaqua-di-iron(II) tetrakis-tetrafluoroborate hydrate (2/1.34) nitromethane solvate
C40H36Fe2N24O2,4(BF4),1.34(H2O),CH3NO2
CrystEngComm (2019) 21, 42 6330
a=19.9235(5)Å b=15.5984(5)Å c=18.6533(4)Å
α=90.00° β=100.512(2)° γ=90.00°
Catena-Bis-[/m-{2-(pyrazol-1-yl)-6-(1,2,4-triazol-1-yl)pyridine}]- bis [2-(pyrazol-1-yl)-6-(1,2,4-triazol-1-yl)pyridine]diaqua-di-iron(II) tetrakis-tetrafluoroborate hydrate (2/1.34) nitromethane solvate
C40H36Fe2N24O2,4(BF4),1.34(H2O),CH3NO2
CrystEngComm (2019) 21, 42 6330
a=19.9190(3)Å b=15.3887(3)Å c=18.5909(3)Å
α=90.00° β=101.152(2)° γ=90.00°
Catena-Bis-[/m-{2-(pyrazol-1-yl)-6-(1,2,4-triazol-1-yl)pyridine}]- bis [2-(pyrazol-1-yl)-6-(1,2,4-triazol-1-yl)pyridine]diaqua-di-iron(II) tetrakis-tetrafluoroborate hydrate (2/0.66) nitromethane solvate
C40H36Fe2N24O2,4(BF4),0.66(H2O),CH3NO2
CrystEngComm (2019) 21, 42 6330
a=19.9010(5)Å b=15.9683(4)Å c=18.7282(6)Å
α=90.00° β=99.397(3)° γ=90.00°
Catena-Bis-[/m-{2-(pyrazol-1-yl)-6-(1,2,4-triazol-1-yl)pyridine}]- bis [2-(pyrazol-1-yl)-6-(1,2,4-triazol-1-yl)pyridine]diaqua-di-iron(II) tetrakis-tetrafluoroborate hydrate (2/1) nitromethane solvate
C40H36Fe2N24O2,4(BF4),H2O,CH3NO2
CrystEngComm (2019) 21, 42 6330
a=19.9189(6)Å b=15.8603(5)Å c=18.7484(4)Å
α=90.00° β=99.528(2)° γ=90.00°
Catena-[2-amino-4,6-(pyrazol-1-yl)pyrimidine]-di-isothiocyanato iron(II)
C12H9FeN9S2
Dalton Transactions (2019)
a=16.0404(2)Å b=16.0404(2)Å c=25.1086(3)Å
α=90.00° β=90.00° γ=90.00°
Catena-[2,4,6-tri(pyrazol-1-yl)-1,3,5-triazine](methanol)silver(I) tetrafluoroborate
C13H13AgN9O,BF4
Dalton transactions (Cambridge, England : 2003) (2018) 47, 15 5269-5278
a=15.4505(4)Å b=13.9523(4)Å c=16.3341(4)Å
α=90.00° β=90.00° γ=90.00°
2,4-Di(pyrazol-1-yl)-6H-1,3,5-triazine
C9H7N7
Dalton transactions (Cambridge, England : 2003) (2018) 47, 15 5269-5278
a=14.3972(8)Å b=4.1060(2)Å c=16.4295(11)Å
α=90.00° β=103.275(7)° γ=90.00°
Bis[2,4,6-tri(pyrazolyl-1-yl)pyridine]bis(acetonitrile)disilver(I) ditetrafluoroborate bis-acetonitrile solvate
C32H28Ag2N16,2(BF4),2(C2H3N)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 15 5269-5278
a=12.0945(3)Å b=6.8744(2)Å c=26.4084(6)Å
α=90.00° β=93.926(2)° γ=90.00°
Catena-bis[2,4,6-tri(pyrazolyl-1-yl)pyridine]disilver(I) ditetrafluoroborate nitromethane solvate
C28H22Ag2N14,2(BF4),CH3NO2
Dalton transactions (Cambridge, England : 2003) (2018) 47, 15 5269-5278
a=12.1548(7)Å b=12.6789(8)Å c=13.5860(8)Å
α=66.821(6)° β=65.231(5)° γ=72.775(5)°
Catena-[2,4,6-tri(pyrazol-1-yl)-1,3,5-triazine]silver(I)tetrafluoroborate nitromethane solvate
C12H9AgN9,BF4,CH3NO2
Dalton transactions (Cambridge, England : 2003) (2018) 47, 15 5269-5278
a=10.8501(6)Å b=12.4336(6)Å c=14.5101(9)Å
α=90.00° β=108.445(7)° γ=90.00°
Bis[2,4,6-tri(pyrazolyl-1-yl)pyridine]disilver(I) ditetrafluoroborate nitromethane (0.5/0.3) solvate
C28H22Ag2N14,2(BF4),0.3(CH3NO2)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 15 5269-5278
a=25.2916(6)Å b=11.6686(3)Å c=23.1019(5)Å
α=90.00° β=91.719(2)° γ=90.00°
Catena-[2,4,6-tri(pyrazol-1-yl)-1,3,5-triazine]silver(I) tetrafluoroborate
C12H9AgN9,BF4
Dalton transactions (Cambridge, England : 2003) (2018) 47, 15 5269-5278
a=17.9041(8)Å b=10.1194(3)Å c=18.2383(6)Å
α=90.00° β=90.00° γ=90.00°
Catena-[2,4,6-tri(pyrazol-1-yl)-1,3,5-triazine]silver(I) perchlorate
C12H9AgN9,ClO4
Dalton transactions (Cambridge, England : 2003) (2018) 47, 15 5269-5278
a=18.3941(9)Å b=10.1003(3)Å c=18.0884(7)Å
α=90.00° β=90.00° γ=90.00°
Pentakis-[2,4,6-tri(pyrazol-1-yl)pyrimidine]-pentasilver(I)penta-tetrafluoroborate dinitromethane solvate
C52H40Ag5N32,5(BF4),2(CH3NO2)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 15 5269-5278
a=29.8766(6)Å b=10.9444(2)Å c=25.5649(8)Å
α=90.00° β=115.208(2)° γ=90.00°
Catena-[2,4-di(pyrazol-1-yl)-1,3,5-triazine]silver(I)tetrafluoroborate
C9H7AgN7,BF4
Dalton transactions (Cambridge, England : 2003) (2018) 47, 15 5269-5278
a=5.6623(1)Å b=14.2076(3)Å c=7.7351(2)Å
α=90.00° β=91.837(2)° γ=90.00°
Bis[2,4,6-tri(pyrazolyl-1-yl)pyrimidine]bis(acetonitrile)disilver(I) ditetrafluoroborate
C30H26Ag2N18,2(BF4)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 15 5269-5278
a=11.3714(3)Å b=6.8555(2)Å c=23.7996(6)Å
α=90.00° β=90.420(2)° γ=90.00°
Catena-[2,4-di(4-chloropyrazol-1-yl)-6H-1,3,5-triazine]silver(I) perchlorate
C9H5AgCl3N7O4
Dalton Transactions (2019)
a=8.0112(2)Å b=10.5868(3)Å c=16.9917(3)Å
α=90.00° β=95.332(2)° γ=90.00°